Board Member
Mangoceuticals, Inc. (MGRX)Equibles does not estimate personal net worth.
Get an email with a short summary when Mangoceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get MGRX alertsJacob D. Cohen is recorded as Board Member at Mangoceuticals, Inc. (MGRX) since January 1, 2021. The newest filing on record that lists Jacob D. Cohen as Board Member at Mangoceuticals, Inc. (MGRX) is dated May 16, 2024. Mangoceuticals, Inc. reported in an 8-K filed July 30, 2026 that Jacob D. Cohen was appointed President. Mangoceuticals, Inc. reported in an 8-K filed July 30, 2026 that Jacob D. Cohen was terminated as Chief Executive Officer. The proxy statement of Mangoceuticals, Inc. reports total compensation of $598,256 for Jacob D. Cohen in fiscal 2023, including a base salary of $260,000. Disclosed compensation is on record for 2 fiscal years. Mangoceuticals, Inc. is classified in the Health Information Services industry within the Healthcare sector. Other leadership on record at Mangoceuticals, Inc. includes Josef Freundorfer (CEO), Sagar Sanghera (Chairman and Board Member), Eugene M. Johnston (CFO and Board Member) and 6 others.
“Effective upon the Separation Date, Mr. Cohen will transition to the role of President of the Company in an independent consulting capacity pursuant to the Consulting Agreement referenced in Item 1.01 above.”
“effective upon the closing of the Transaction contemplated by the BCA, Jacob D. Cohen's employment as Chief Executive Officer of the Company will terminate upon closing of the Transaction.”
SEC 8-K
2026-07-30–present
2021-01-01–present
Last confirmed May 16, 2024
MGRX
Health Information Services · Healthcare
Board Member
2021-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Mangoceuticals, Inc. (MGRX) | CEO and Chairman | $260,000 | $598,256 |
| 2022 | Mangoceuticals, Inc. (MGRX) | CEO and Chairman | $70,000 | $632,750 |
